July 2014

Newsletter-Banner

Webinar Series on Alzheimer’s Disease and Related Dementias Launches

The Administration for Community Living, Centers for Disease Control andPrevention, and the National Institute on Aging have collaborated on a webinar series focused on increasing knowledge about Alzheimer’s disease and related dementias. These webinars serve as resources that public health, aging services and research network professionals can use to inform, educate and empower community members, people with dementia and their family caregivers. More info can be found here.

2013-2014 Alzheimer’s Disease Progress Report Now Available

The 2013-2014 Alzheimer’s Disease Progress Report: Insights and Challenges is now available from the National Institutes of Health and the NIA. It gives an overview of recent Alzheimer’s disease research advances and new initiatives from the NIH. It’s a great resource; we encourage you to share it with anyone interested in learning more about Alzheimer’s. It’s available here.

National Memory Screening Day Is November 18

The Alzheimer’s Foundation of America sends an invitation to health care professionals to participate in this year’s annual National Memory Screening Day. It takes place on Tuesday, November 18, 2014. Community sites across the country will offer FREE, confidential memory screenings and educational materials to the public.

Path to Fund Development of Alzheimer’s Drugs Suggested

In an article in Science Translational Medicine, experts from the MIT Sloan School of Management outlined a path that they say could offer better avenues to fund development of Alzheimer’s drugs. This plan calls for a public-private partnership approach to funding. It’s an interesting read. You can check out the original article here and and an article in the Wall Street Journal.

NIH Sends Out Call for Participants for A4 Clinical Trial

The NIH has sent out a call for volunteers to participate in a major clinical trial study that will test to see whether an experimental drug called solanezumab can help slow memory loss associated with Alzheimer’s. The volunteers need to be between 65 and 85 with normal memory but who may be at risk for Alzheimer’s. Program information can be found here.

2014 Alzheimer’s Association International Conference Resources Available

As you were probably aware, the 2014 Alzheimer’s Association International Conference took place in Copenhagen, Denmark. We wanted to share a link to its resource page in case you would like to explore the presentations and other materials. Here’s the link.

7th Annual FDA/Alzheimer’s Disease Allies Meeting Set for November 6th

Make sure you mark November 6, 2014 on your calendars. ACT-AD will host its 7th Annual FDA/Alzheimer’s Disease Allies Meeting for patient groups, regulators, researchers and industry at the Bethesda North Marriott Hotel & Conference Center (5701 Marinelli Rd., Bethesda, MD 20852). This meeting will explore challenges related to clinical meaningfulness in therapeutic development for early Alzheimer’s disease. Check out this page for updates.